DarioHealth Corp reports results for the quarter ended December 31 - Earnings Summary

• DarioHealth Corp DRIO.OQ reported a quarterly adjusted loss of 9 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -50 cents. The mean expectation of three analysts for the quarter was for a loss of 33 cents per share. Wall Street expected results to range from -43 cents to -26 cents per share.

• Revenue rose 110.3% to $7.60 million from a year ago; analysts expected $7.39 million.

• DarioHealth Corp's reported EPS for the quarter was a loss of 9 cents​.

• The company reported a quarterly loss of $12.26 million.

• DarioHealth Corp shares had fallen by 7.3% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for DarioHealth Corp is $3.50

This summary was machine generated from LSEG data March 10 at 02:52 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)